Braeburn Pharmaceuticals, Inc.
Pharmaceutical company · Princeton, New Jersey, United States
Braeburn Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2018.
Braeburn Pharmaceuticals at a glance
What does Braeburn Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $110 million sold (2018).
Frequently asked questions about Braeburn Pharmaceuticals
Where is Braeburn Pharmaceuticals headquartered?
Braeburn Pharmaceuticals, Inc. is headquartered in Princeton, New Jersey, United States.
What does Braeburn Pharmaceuticals do?
Braeburn Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Soligenix, Inc.Princeton, New Jersey, United States
- PDS Biotechnology CorpPrinceton, New Jersey, United States
- Enalare Therapeutics Inc.Princeton, New Jersey, United States
- Amicus Therapeutics, Inc.Princeton, New Jersey, United States
- Bristol Myers Squibb CoPrinceton, New Jersey, United States
- Grace Therapeutics, Inc.Princeton, New Jersey, United States
- PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
- Church & Dwight Co., Inc.Princeton, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences